Trappetti, VerdianaVerdianaTrappetti0000-0002-7276-833XPotez, Marine Therese CharletteMarine Therese CharlettePotezFernandez Palomo, Cristian GabrielCristian GabrielFernandez Palomo0000-0002-5095-262XVolarevic, VladislavVladislavVolarevicShintani, NahokoNahokoShintaniPellicioli, PaoloPaoloPellicioliErnst, Alexander Uwe JohannAlexander Uwe JohannErnst0000-0002-4956-315XHaberthür, DavidDavidHaberthür0000-0003-3388-9187Fazzari, Jennifer MichelinaJennifer MichelinaFazzariKrisch, MichaelMichaelKrischLaissue, Jean AJean ALaissueAnderson, Robin LRobin LAndersonMartin, Olga AlexeevnaOlga AlexeevnaMartinDjonov, Valentin GeorgievValentin GeorgievDjonov0000-0002-5062-11692024-10-112024-10-112022-11-01https://boris-portal.unibe.ch/handle/20.500.12422/86582PURPOSE Synchrotron-generated microbeam radiotherapy (MRT) represents an innovative preclinical type of cancer radiotherapy with an excellent therapeutic ratio. Beyond local control, metastatic spread is another important endpoint to assess the effectiveness of radiotherapy treatment. Currently, no data exists on an association between MRT and metastasis. Here, we evaluated the ability of MRT to delay B16F10 murine melanoma progression and locoregional metastatic spread. METHODS AND MATERIALS We assessed the primary tumor response and the extent of metastasis in sentinel lymph nodes in two cohorts of C57BL/6J mice, one receiving a single MRT and another receiving two MRT delivered with a 10-day interval. We compared these two cohorts with synchrotron broad beam-irradiated and non-irradiated mice. In addition, using multi-plex quantitative platforms, we measured plasma concentrations of 34 pro- and anti-inflammatory cytokines and frequencies of immune cell subsets infiltrating primary tumors that received either one or two MRT treatments. RESULTS Two MRT treatments were significantly more effective for local control than single MRT. Remarkably, the second MRT also triggered a pronounced regression of out-of-radiation field locoregional metastasis. Augmentation of CXCL5, CXCL12 and CCL22 levels after the second MRT indicated that inhibition of melanoma progression could be associated with increased activity of anti-tumor neutrophils and T-cells. Indeed, we demonstrated elevated infiltration of neutrophils and activated T-cells in the tumors following the second MRT. CONCLUSIONS Our study highlights the importance of monitoring metastasis following MRT and provides the first MRT fractionation schedule that promotes local and locoregional control with the potential to manage distant metastasis.en500 - Science::570 - Life sciences; biology600 - Technology::610 - Medicine & healtharticle10.48350/1718253593416110.1016/j.ijrobp.2022.06.090